WebAlpha-fetoprotein (AFP), Lens culinaris-agglutinin-reactive fraction of AFP (AFP-L3), and protein induced by vitamin K absence or antagonist-II (PIVKA-II) are widely used as tumor markers for the diagnosis of hepatocellular carcinoma (HCC).This study compared the diagnostic values of AFP, AFP-L3, and PIVKA-II individually and in combination to find … WebMar 10, 2024 · PIVKA-II was also reported as a prognosis marker in patients with HCC, as PIVKA-II and AFP have a positive correlation with the tumor burden [ 10 ]. High serum levels of PIVKA-II
(PDF) Clinical evaluation of Elecsys PIVKA-II for patients with ...
WebApr 6, 2024 · PIVKA-II would be a better biomarker for predicting tumor size in HCC than AFP, since although patients with a tumor size > 3 cm had higher serum levels of both biomarkers, AFP did not correlate ... WebMay 25, 2024 · e16608 Background: Protein Induced by Vitamin K Absence-II (PIVKA-II) is a tumor marker specific for hepatocellular carcinoma (HCC). PIVKA-II levels correspond with HCC oncogenesis and disease progression. Portal vein tumor thrombus (PVTT) in patients with HCC is a significant factor that affect treatment and prognosis. In this study … oaa chaplain residents
Usefulness of AFP, AFP-L3, and PIVKA-II, and their... : Medicine
WebJan 20, 2024 · Serum tumor markers for HCC, including alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II), were evaluated at baseline and 2-3 weeks after therapy was ... WebStudy results are inconsistent in terms of which marker is better; some findings support the PIVKA-II, 26–29 and some support the AFP. 30–32 But one thing was unanimous that the combination of two biomarkers is superior to the use of a single biomarker. 24,32–35 Our study found there was a weak correlation between the two markers. Among ... WebAim: The aim of this study was to evaluate the clinical contribution of protein induced by vitamin K absence (PIVKA-II) for hepatocellular carcinoma (HCC) diagnostics and … oa acknowledgment\u0027s